Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Medical Physics|May 18, 2017
Sci-Thurs PM: Delivery-07: Evaluation of prospects to use daily megavoltage CT studies for adaptive radiotherapyS Yartsev, C Woodford, A R Dar, et al.
International Journal of Radiation Oncology, Biology, Physics|April 8, 1998
Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?O Vujovic, F Perera, A R Dar, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1997
Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrenceB J Fisher, F E Perera, A L Cooke, et al.
International Journal of Radiation Oncology, Biology, Physics|October 27, 1998
Postoperative radiotherapy for Stage I/II seminoma: results for 212 patientsG S Bauman, V M Venkatesan, C T Ago, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1997
Superior vena cava obstruction in small-cell lung cancerR H Chan, A R Dar, E Yu, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 1997
Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?B J Fisher, F E Perera, A L Cooke, et al.
Chest|February 12, 2000
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology GroupW Sause, P Kolesar, I V Taylor S, et al.
Medical and Pediatric Oncology|January 1, 1996
Childhood medulloblastoma in Ontario, 1977-1987: population-based resultsC E Danjoux, R D Jenkin, J McLaughlin, et al.
Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease controlG M Videtic, K Fung, A T Tomiak, et al.
International Journal of Radiation Oncology, Biology, Physics|December 29, 1999
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studiesB Movsas, C Scott, W Sause, et al.
Pageof 2